Robotic-assisted surgery and artificial intelligence in female infertility: a clinical maturity framework for evidence-based integration

Abstract Background Female infertility often requires coordinated diagnostic, surgical, and assisted reproductive strategies. Robotic-assisted surgery (RAS) may facilitate selected fertility-preserving procedures, while artificial intelligence (AI) is increasingly applied to reproductive imaging, embryo assessment, ovarian stimulation, prognosis, and clinical decision support. The clinical evidence for both technologies is uneven, and direct AI integration into robotic infertility surgery remains early. Main body This critical review evaluates current evidence for RAS in myomectomy, tubal reanastomosis, endometriosis surgery, adhesiolysis, ovarian surgery, and selected reconstructive procedures, alongside clinically relevant AI applications in assisted reproduction and reproductive imaging. RAS may offer technical advantages in complex cases through enhanced visualization, instrument articulation, ergonomics, and suturing, but superiority over expert conventional laparoscopy for cumulative live birth, time to pregnancy, ovarian reserve preservation, and cost-effectiveness remains insufficiently established. AI can improve standardization and prediction, but many models remain retrospective, internally validated, incompletely calibrated, or insufficiently tested for clinical utility. We propose a clinical maturity framework that distinguishes current surgeon-controlled RAS from research-stage AI support and speculative autonomous surgery. The most plausible near-term AI-RAS integration is clinician-supervised support for preoperative imaging, surgical difficulty prediction, intraoperative video analytics, robotic skill assessment, postoperative fertility prognosis, and sequencing of surgery and assisted reproductive technology. Conclusion AI and RAS may become complementary components of female infertility care, but routine integrated use requires multicenter prospective validation, standardized infertility-specific outcomes, transparent AI reporting, patient-centered evaluation, regulatory oversight, and assessment of cost and equity.

Authors

Institutions

Publication Details

Journal
Middle East Fertility Society Journal
Published
2026-11-17
DOI
https://doi.org/10.1186/s43043-026-00370-w
Primary Topic
Reproductive Health and Technologies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Robotic-assisted surgery and artificial intelligence in female infertility: a clinical maturity framework for evidence-based integration

Mahsa Motamed, Masoud Saadat Fakhr, Koosha Amiri, Poorya Gholami et al.
2 links
Middle East Fertility Society Journal
Reproductive Health and Technologies
article

Robotic-assisted surgery and artificial intelligence in female infertility: a clinical maturity framework for evidence-based integration

Mahsa Motamed, Masoud Saadat Fakhr, Koosha Amiri, Poorya Gholami, Sadaf Saket, Mona Abediasl, Zahra Amini, Shahrzade Valizadehashenaabad
article en

Abstract

Abstract Background Female infertility often requires coordinated diagnostic, surgical, and assisted reproductive strategies. Robotic-assisted surgery (RAS) may facilitate selected fertility-preserving procedures, while artificial intelligence (AI) is increasingly applied to reproductive imaging, embryo assessment, ovarian stimulation, prognosis, and clinical decision support. The clinical evidence for both technologies is uneven, and direct AI integration into robotic infertility surgery remains early. Main body This critical review evaluates current evidence for RAS in myomectomy, tubal reanastomosis, endometriosis surgery, adhesiolysis, ovarian surgery, and selected reconstructive procedures, alongside clinically relevant AI applications in assisted reproduction and reproductive imaging. RAS may offer technical advantages in complex cases through enhanced visualization, instrument articulation, ergonomics, and suturing, but superiority over expert conventional laparoscopy for cumulative live birth, time to pregnancy, ovarian reserve preservation, and cost-effectiveness remains insufficiently established. AI can improve standardization and prediction, but many models remain retrospective, internally validated, incompletely calibrated, or insufficiently tested for clinical utility. We propose a clinical maturity framework that distinguishes current surgeon-controlled RAS from research-stage AI support and speculative autonomous surgery. The most plausible near-term AI-RAS integration is clinician-supervised support for preoperative imaging, surgical difficulty prediction, intraoperative video analytics, robotic skill assessment, postoperative fertility prognosis, and sequencing of surgery and assisted reproductive technology. Conclusion AI and RAS may become complementary components of female infertility care, but routine integrated use requires multicenter prospective validation, standardized infertility-specific outcomes, transparent AI reporting, patient-centered evaluation, regulatory oversight, and assessment of cost and equity.

Middle East Fertility Society JournalVol. 31(1)
Islamic Azad University, Tehran (IR), Shahid Beheshti University of Medical Sciences (IR), Tehran University of Medical Sciences (IR)
Good health and well-being
Reproductive Health and Technologies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon